ask="12.10"
ask_size="300"
average_daily_volume="168487"
bid="8.20"
bid_size="200"
book_value="3.69"
change="+0.50"
change_from_200_day_moving_average="2.00"
change_from_50_day_moving_average="-0.39"
change_from_52_week_high="-2.70"
change_From_52_week_low="8.02"
change_in_percent="+4.39%"
close="11.90"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.17"
ebitda="-38.95M"
eps_estimate_current_year="-2.13"
eps_estimate_next_quarter="-0.54"
eps_estimate_next_year="-1.88"
ex_dividend_date="N/A"
float_shares="15630000"
high="12.05"
high_52_weeks="14.60"
last_trade_date="1/4/2017"
last_trade_price="11.90"
last_trade_size="5986"
last_trade_time="4:00pm"
low="11.34"
low_52_weeks="3.88"
market_capitalization="212.37M"
moving_average_200_day="9.90"
moving_average_50_day="12.29"
name="Stemline Therapeutics
Inc."
notes="N/A"
one_year_target_price="28.25"
open="11.50"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+20.24%"
percent_change_from_50_day_moving_average="-3.18%"
percent_change_from_52_week_high="-18.49%"
percent_change_from_52_week_low="+206.70%"
previous_close="11.40"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.09"
price_per_sales="214.69"
revenue="947604.00"
shares_outstanding="17846000"
short_ratio="6.77"
stock_exchange="NCM"
symbol="STML"
volume="114464"
weeks_range_52="3.88 - 14.60"
